New Budget Bill Short Shrifts Science

The omnibus spending bill unveiled by US Congress this week would restore some research budgets cut by sequestration, but critics say it's not enough.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, KMCCOYThe US Congress rolled out an omnibus $1.1 trillion spending bill on Monday (January 13) that would keep the government in operation through October. The bipartisan bill, which was authored by House Appropriations Committee Chairman Harold Rogers (R-KY) and Senate counterpart Barbara Mikulski (D-MD), slates $29.934 billion in funding for the National Institutes of Health (NIH), a $1 billion increase from the agency’s sequester-wracked 2013 budget.

But this boost isn’t large enough, according to many in the research community. “The FY14 omnibus spending bill falls short of restoring funding for lifesaving National Institutes of Health (NIH) biomedical research,” said Carrie Wolinetz, president of the biomedical science advocacy group United for Medical Research, in a statement. “The proposed package won’t adequately reverse the damage done by last year’s budget sequester and ensure the nation’s biomedical research enterprise makes continued progress in lifesaving research and development.”

The NIH budget increase contained in the spending bill is, in fact, $714 million less than 2013’s “enacted level” of $30.648 billion, according to House Democrats. And the NIH itself reports that if the bill were to pass, the agency would be getting $950 million less than ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo